BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 25694654)

  • 1. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
    Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
    Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
    Muller A; Bertrand X; Rogues AM; Péfau M; Alfandari S; Gauzit R; Dumartin C; Gbaguidi-Haore H;
    Antimicrob Resist Infect Control; 2018; 7():11. PubMed ID: 29387345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High third-generation cephalosporin resistant Enterobacteriaceae prevalence rate among neonatal infections in Dakar, Senegal.
    Breurec S; Bouchiat C; Sire JM; Moquet O; Bercion R; Cisse MF; Glaser P; Ndiaye O; Ka S; Salord H; Seck A; Sy HS; Michel R; Garin B
    BMC Infect Dis; 2016 Oct; 16(1):587. PubMed ID: 27765017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric Monotherapy Versus Combination Therapy for Enterobacteriaceae Bacteremia in Children.
    Berkowitz NM; Spaeder MC; DeBiasi RL; Campos J; Singh N
    Pediatr Infect Dis J; 2015 Nov; 34(11):1203-6. PubMed ID: 26301498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
    Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
    J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
    Lee CH; Hsieh CC; Hong MY; Hung YP; Ko WC; Lee CC
    Int J Antimicrob Agents; 2017 May; 49(5):617-623. PubMed ID: 28315452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
    O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
    Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy.
    Pinto Pereira LM; Phillips M; Ramlal H; Teemul K; Prabhakar P
    BMC Infect Dis; 2004 Dec; 4(1):59. PubMed ID: 15601475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of third-generation cephalosporin-resistant community-acquired Enterobacteria isolated from elderly patients.
    Thibaut S; Caillon J; Marquet A; Grandjean G; Potel G; Ballereau F;
    Med Mal Infect; 2014 Feb; 44(2):57-62. PubMed ID: 24556454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-center evaluation of the risk for colonization or bacteremia with piperacillin-tazobactam- and cefepime-resistant bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis.
    Nguyen AD; Heil EL; Patel NK; Duffy A; Gilmore S
    J Oncol Pharm Pract; 2016 Apr; 22(2):303-7. PubMed ID: 25567517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of third-generation cephalosporin resistance in Enterobacteriaceae from 2000 to 2008 in a Perpignan hospital].
    Mayoral G; Ferreyra M; Eden A; Gueudet P; Miquel C; Lecaillon E
    Pathol Biol (Paris); 2010 Feb; 58(1):7-10. PubMed ID: 19854588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
    Deelen JWT; Rottier WC; Giron Ortega JA; Rodriguez-Baño J; Harbarth S; Tacconelli E; Jacobsson G; Zahar JR; van Werkhoven CH; Bonten MJM;
    Clin Infect Dis; 2021 Dec; 73(11):e4475-e4483. PubMed ID: 32640024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae.
    Renvoisé A; Decré D; Amarsy-Guerle R; Huang TD; Jost C; Podglajen I; Raskine L; Genel N; Bogaerts P; Jarlier V; Arlet G
    J Clin Microbiol; 2013 Dec; 51(12):4012-7. PubMed ID: 24068012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India.
    Bharadwaj R; Robinson ML; Balasubramanian U; Kulkarni V; Kagal A; Raichur P; Khadse S; Kadam D; Valvi C; Kinikar A; Kanade S; Suryavanshi N; Marbaniang I; Nelson G; Johnson J; Zenilman J; Sachs J; Gupta A; Mave V
    BMC Infect Dis; 2018 Oct; 18(1):504. PubMed ID: 30286741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.